Comparative absorption and variability in absorption of estradiol from a transdermal gel and a novel matrix-type transdermal patch

被引:22
作者
Järvinen, A
Bäckström, AC
Elfström, C
Viitanen, A
机构
[1] Univ Helsinki, Cent Hosp, Dept Med, Hus 00029, Finland
[2] Orion Corp, Orion Pharma, Espoo, Finland
[3] Quintiles AB, Uppsala, Sweden
关键词
hormone replacement therapy; pharmacokinetics; estradiol; transdermal; variability;
D O I
10.1016/S0378-5122(00)00222-X
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objectives: To compare the absorption of estradiol from a transdermal gel and a novel matrix-type patch and to study the variability in absorption. Methods: Twenty-four healthy postmenopausal women were treated in an open, randomized cross-over study for 18 days with 1.0 mg estradiol daily as a transdermal gel and a transdermal patch releasing estradiol 50 mug/24 h without a wash-out between the periods. Venous blood samples for estradiol pharmacokinetics were taken on the 15th and 18th study days of the gel period and during the 15th-18th study days during the patch period. Results: There was no significant difference in peak estradiol level or area under the estradiol time-concentration curve between the gel and the patch. However, trough estradiol concentration was significantly lon er and fluctuation higher. with the patch. Estradiol time-concentration curves on the 15th and 18th study days with the gel were almost superimposable, A significant. difference was observed in peak estradiol levels? whereas area under the curve or trough estradiol level did not differ between the 15th and 18th study days with the gel. Inter- and intra-individual coefficients of variability were around 30% for peak estradiol level and area under the curve. except for the intra-individual coefficient of variability for area under the curve (21%) for the gel. The total coefficient of variability for area under the curve was 35% for the gel and 39% for the patch. Conclusions: A daily 1.0 my estradiol dose as a transdermal gel seems to correspond with a matrix-type patch releasing 50 mug estradiol daily in the extent of estradiol absorption. High variability was associated with both treatments, and both the variabilities within and between the subjects were high with the gel. Wider than generally applied confidence limits should be applied for bioequivalence testing of transdermal estradiol formulations. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:189 / 196
页数:8
相关论文
共 18 条
[1]   COMPARATIVE BIOAVAILABILITY STUDY OF A MATRIX VERSUS A RESERVOIR TRANSDERMAL ESTRADIOL PATCH IN HEALTHY POSTMENOPAUSAL WOMEN [J].
BARACAT, E ;
TUFIK, S ;
CASTELO, A ;
DELIMA, GR ;
HAIDAR, M ;
CASOY, J ;
PELOSO, U .
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1995, 56 (04) :358-368
[2]   Plasma concentration of estradiol after transdermal administration of Systen(R)50 (Evorel(R)) or Menorest(R)50 [J].
Blacker, C ;
Brion, N ;
Caulin, F ;
Mayolle, C ;
Reginster, JY ;
Regnard, A ;
Scholler, R .
CLINICAL DRUG INVESTIGATION, 1996, 11 (06) :339-346
[3]   BIOLOGIC EFFECTS OF TRANSDERMAL ESTRADIOL [J].
CHETKOWSKI, RJ ;
MELDRUM, DR ;
STEINGOLD, KA ;
RANDLE, D ;
LU, JK ;
EGGENA, P ;
HERSHMAN, JM ;
ALKJAERSIG, NK ;
FLETCHER, AP ;
JUDD, HL .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (25) :1615-1620
[4]   The metabolic consequences of treating postmenopausal women with non-oral hormone replacement therapy [J].
Crook, D .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1997, 104 :4-13
[5]   EFFECT OF GRADED ORAL DOSES OF ESTRADIOL ON CIRCULATING HORMONAL LEVELS [J].
DADA, OA ;
LAUMAS, V ;
LANDGREN, BM ;
CEKAN, SZ ;
DICZFALUSY, E .
ACTA ENDOCRINOLOGICA, 1978, 88 (04) :754-767
[6]   BIOLOGICAL EFFECTS OF VARIOUS DOSES OF CONJUGATED EQUINE ESTROGENS IN POST-MENOPAUSAL WOMEN [J].
GEOLA, FL ;
FRUMAR, AM ;
TATARYN, IV ;
LU, KH ;
HERSHMAN, JM ;
EGGENA, P ;
SAMBHI, MP ;
JUDD, HL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1980, 51 (03) :620-625
[7]   Effects of transdermal oestrogen therapy in postmenopausal women: a comparative study of an oestradiol gel and an oestradiol delivering patch [J].
Hirvonen, E ;
Cacciatore, B ;
Wahlstrom, T ;
Rita, H ;
WilenRosenqvist, G .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1997, 104 :26-31
[8]   A COMPARISON OF LIVER PROTEIN INDUCTION IN POST-MENOPAUSAL WOMEN DURING ORAL AND PERCUTANEOUS ESTROGEN REPLACEMENT THERAPY [J].
HOLST, J ;
CAJANDER, S ;
CARLSTROM, K ;
DAMBER, MG ;
VONSCHOULTZ, B .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1983, 90 (04) :355-360
[9]   Steady-state pharmacokinetics of oestradiol gel in post-menopausal women: Effects of application area and washing [J].
Jarvinen, A ;
Granander, M ;
Nykanen, S ;
Laine, T ;
Geurts, P ;
Viitanen, A .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1997, 104 :14-18
[10]   Absorption and bioavailability of oestradiol from a gel, a patch and a tablet [J].
Järvinen, A ;
Nykänen, S ;
Paasiniemi, L .
MATURITAS, 1999, 32 (02) :103-113